Recent Headlines
Within Biotechnology
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
Nanohybrids Expands Nanoparticle Product Line with Launch of 30 nm Gold Nanospheres
NanoHybrids releases 30 nm spherical gold nanoparticles. With this product launch NanoHybrids now offers a full complement of NanoSphere products ranging in diameter from 5 nm to 60 nm. Various surface coatings are also available to suit a wide range of application needs. - April 20, 2016 - NanoHybrids
Jivana Biotechnology Inc Announces Additions to Its Advisory Committee
Jivana Biotechnology adds Patrick Sage and Dr Frank Facchini to its advisory committee. - April 16, 2016 - Jivana Biotechnology Inc
Montana Molecular Appoints MoBiTec, Germany, as Distributor to Sell Genetically Encoded Fluorescent Biosensors
While fluorescent dye-based assays are powerful tools for high-throughput screening in engineered cell lines or cell lysates to show that signaling has occurred, genetically encoded sensors that measure dynamic processes in physiologically relevant cells provide a higher level of insight into how signals are regulated in both space and time. It is the regulation of signaling that controls cell function in both health and disease. - April 16, 2016 - MoBiTec GmbH
ImaBiotech Signs License Agreement with Lawrence Berkeley National Laboratory
ImaBiotech, a CRO company developing and offering mass spectrometry imaging (MSI) services, applications, and software, announces today a license agreement with Lawrence Berkeley National Laboratory (Berkeley Lab) to “OpenMSI” intellectual property to support ImaBiotech... - April 16, 2016 - Imabiotech
Arteric Appoints New Director of Technology Fast-Growing Pharmaceutical and Biotechnology Digital Agency Broadens Its Digital Healthcare Capabilities with 15-Year Veteran
Arteric is pleased to announce that Jon Fisher has joined Arteric as its new Director of Technology. Jon has worked in technology and digital marketing for 15 years and has spent the past 9 years working in a healthcare marketing agency. - April 15, 2016 - Arteric
The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy
VIRUN® plans on taking Orlando by storm at Ingredient Marketplace, where Virun’s Esolv® technology will take center stage, and Virun’s unique Omega smoothies and beverages will be available for sampling. South Korea granted Virun yet another patent protecting its unique technology. Virun launches new products and a new t-shirt. Virun’s latest webinar, “Inside Virun,” sparks controversy, and provides new business opportunities. - April 12, 2016 - VIRUN
Arteric Appoints New Group Account Supervisor; Fast-Growing Pharmaceutical and Biotechnology Digital Agency Strengthens Account Services
Arteric (http://arteric.com) is excited to introduce Heather Eckhaus as its new Group Account Supervisor. Heather joins Arteric from DigitasLBi in New York, where she led the Pitney Bowes account, with key initiatives including the global redesign and rebuild of pitneybowes.com as well as the... - April 11, 2016 - Arteric
NICE Provides Positive Guidance on electroCore’s gammaCore Treatment for the Prevention and Acute Treatment of Migraine and Cluster Headache
The UK’s National Institute of Health and Care Excellence (NICE) has published guidance that electroCore’s non-invasive vagus nerve stimulation treatment (gammaCore) for the prevention and acute treatment of migraine and cluster headache is safe and can now be used in the NHS. The... - April 09, 2016 - electroCore
ValueCentric Expands Specialty Data Quality and Performance Measurement Reporting Capabilities
Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric
ALPCO's New Chemiluminescent IL-6 ELISA Delivers Flexibility and Cost Savings
ALPCO announced the launch of its new STELLUX® Chemi Human IL-6 ELISA - the first cytokine assay in the STELLUX® Chemiluminescence product line. - April 06, 2016 - ALPCO
African Biosciences Inc. Launches First Ever E-Commerce Platform for Bioscience Reagents and Supplies in Nigeria
African Biosciences Ltd., a subsidiary of US-based African Biosciences Inc. today announced the launching of the first ever e-commerce platform in Nigeria to provide reagents and supplies to the bioscience and clinical research community. African Biosciences Ltd. is the first company to use an e-commerce driven model to deliver reagents and supplies to meet the needs of researchers into the biology of animals, humans, microbes and plants and medical testing laboratories in Nigeria. - April 04, 2016 - African Biosciences Inc.
Video Series Educates Families on Brain Tumors
In the Pediatric Brain Tumor Foundation’s new Family Support Learning Series videos, leading brain tumor experts discuss topics such as clinical trials, genetic susceptibility and molecular testing. - March 31, 2016 - Pediatric Brain Tumor Foundation
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
MiTeGen Announces Their In Situ-1 Crystallization Plates Have Been Selected for Use in Microgravity Crystallization Experiments Aboard the International Space Station
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced that a line of their products, the In Situ-1™ crystallization plates, will be used for research conducted on the International Space Station (ISS). - March 24, 2016 - MiTeGen, LLC
New Bioreactor Tubing Kits from AdvantaPure(R) Speed Turnaround and Increase Processing Capacity; Single-Use and Customizable for Benchtop Bioreactors
Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors. Because the kits arrive preassembled, they provide quicker turnaround time, convenience and less chance of cross contamination. Platinum-cured silicone or AdvantaFlex(R) TPE tubing may be selected as the tubing components in each kit. This product will be exhibited at Interphex booth 3055. - March 24, 2016 - AdvantaPure
MFB Fertility, LLC Develops Only In-Home Test to Detect Progesterone
Research has shown that couples get pregnant faster when they know when exactly when ovulation takes place. Fertility monitors and ovulation predictor kits allow couples to track estrogen and luteinizing hormone (LH) levels from home. However, until now, there were no tests available to track progesterone. - March 23, 2016 - MFB Fertility, LLC
HPAPIs and Cytotoxic Drugs: The Growing Opportunity for Contract Manufacturers
Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition) report to its portfolio. The report provides an extensive study of the contract manufacturing opportunity in this rapidly expanding market. The focus of this report is primarily to... - March 21, 2016 - Roots Analysis
Bioo Scientific Launches ELISA for Screening of Ethoxyquin in Fishmeal, Fish, Shrimp, Feed and Meat
Bioo Scientific has released a new screening method, the MaxSignal® Ethoxyquin ELISA Test Kit to test fishmeal, fish, shrimp, feed and meat for ethoxyquin (EQ) residues. - March 19, 2016 - Bioo Scientific
Bioo Scientific Granted Patent for Small RNA Sequencing Technology
The United States Patent and Trademark Office (USPTO) has issued U.S. patent US9255291 entitled Oligonucleotide ligation, barcoding and methods and compositions for improving data quality and throughput using massively parallel sequencing to Bioo Scientific. - March 17, 2016 - Bioo Scientific
NSF Funds NanoHybrids’ Improved Chemotherapy Delivery Platform
NSF SBIR grant to be used to advance nanoparticle platform for safe, effective, and controlled cancer drug delivery. - March 16, 2016 - NanoHybrids
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
AdvantaPure(R) Introduces BioClosure(R) System Assemblies That Reduce Assembly Time, Protect Product Integrity and Decrease Contamination Risks
Single-Use components supplier AdvantaPure announces the availability of BioClosure System Assemblies. The ready-to-use, closed container systems are designed to save customers time and expense in their bioprocess applications by eliminating cleaning validations, reducing the need for multiple inventoried parts, and assembling onsite. The Single-Use assemblies also help decrease contamination risks. Applications include aseptic sampling, cell growth, filling, process R&D and cold storage. - March 10, 2016 - AdvantaPure
Specialty CROs: The Future of R&D Outsourcing
Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/services, focused on a particular stage of clinical... - March 07, 2016 - Roots Analysis
Spaulding Clinical Research, a Full-Service CRO to Present at the American Society for Clinical Pharmacology and Therapeutics' (ASCPT) 2016 Annual Meeting
Spaulding Clinical Research, LLC, a full-service CRO announced today that they will be in attendance at the American Society for Clinical Pharmacology and Therapeutics’ (ASCPT) 2016 Annual Meeting. The event is scheduled to take place at the Hilton Bayfront in San Diego, California a from... - March 05, 2016 - Spaulding Clinical Research, LLC
Ixogel®: Agreement on Special Protocol Assessment (SPA) by the US Food and Drug Administration for the Prevention of Lyme Disease
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the company has reached agreement with the US Food and Drug Administration (FDA) on the phase III protocol according to the Special Protocol... - March 01, 2016 - Ixodes AG
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
MR Solutions Brings New 3D, 1000X Magnification Imaging Modality to Preclinical Research
MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs. - February 24, 2016 - MR Solutions
ALPCO's New NT-proBNP ELISA Offers Cost Savings and Flexibility
ALPCO recently announced the release of its new NT-proBNP (1-76) ELISA, offering researchers investigating cardiovascular disease, kidney disease, and diabetes with a flexible, user friendly and cost effective tool. The assay is highly characterized to measure changes in levels of NT-proBNP, and... - February 23, 2016 - ALPCO
AdvantaPure(R) Introduces AdvantaFlex® Sterile Molded Tubing Ends to Add Versatility to Tubing
Single-Use, molded, mini Tri-Clamp tubing ends are designed to improve production and reduce operational costs involved with biopharma processes. Made from AdvantaFlex biopharmaceutical grade TPE tubing and an overmolding process, the ends are well suited for aseptic fluid transfer applications. They reduce the potential for leaks and help simplify cleaning and validation procedures. AdvantaFlex Molded Tubing Ends are compatible with sterile tubing welders. - February 21, 2016 - AdvantaPure
Fannin Innovation Studio Names Melissa Singh Principal
Life science commercialization company Fannin Innovation Studio (www.FanninInnovation.com) today promoted its first entrepreneur fellow, biomedical scientist Melissa Singh, Ph.D., to principal. With this move, entrepreneur fellow Erol Bakkalbasi, M.Sc. has been named senior entrepreneur... - February 17, 2016 - Fannin Partners, LLC
ImmunoReagents Introduces LigaTrap™ Purification Resins and Kits
ImmunoReagents is proud to announce LigaTrap™ purification resins and kits. LigaTrap™ technology utilizes novel, patented ligands, designed for antibody purification. Each kit includes 10 spin columns filled with LigaTrap™ resin and buffers needed to capture species-specific... - February 17, 2016 - ImmunoReagents Inc.
ALPCO Releases New Basophil Activation Test Validated for the Evaluation of Kinase Inhibitors in Early Drug Development
ALPCO has released its new InhibiScreen Basophil Activation Test (BAT) which was developed and validated specifically for the evaluation of kinase inhibitors during early drug development. - February 16, 2016 - ALPCO
Peptide Therapeutics: The Growing Hope for Metabolic Disorders
Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook of the evolving pipeline of peptide therapeutics that are being... - February 16, 2016 - Roots Analysis
NuvOx Pharma receives FDA Orphan Drug Designation for Oxygen Therapeutic for Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of... - February 14, 2016 - NuvOx Pharma
cliexa™ Launched Its first Rheumatoid Arthritis Disease Activity Tracking Mobile Application, cliexa-RA
Collaborative Network 4 Clinical Excellence, LLC (CN4CE) has just launched their first mobile chronic disease tracking application, cliexa-RA. cliexa-RA is available for iOS devices in the App Store. It tracks medications, symptoms and disease activity for Rheumatoid Arthritis. The Clinical... - February 13, 2016 - cliexa
NuvOx Pharma Announces FDA Acceptance of IND to Initiate Clinical Trial for Vaso-Occlusive Crisis in Sickle Cell Disease
The FDA has notified NuvOx Pharma that it may proceed with a clinical trial for its Investigational New Drug (IND), NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of sickle cell disease and it typically... - February 13, 2016 - NuvOx Pharma
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens
Italian research group uses Epitope Diagnostics' Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. - February 11, 2016 - Epitope Diagnostics, Inc.
NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter
NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life sciences, will begin production of their WOLF Cell Sorter. The Series A investment was led by Ken Hood of San Diego’s FusionX Ventures, an early-stage investment fund. - February 08, 2016 - NanoCellect
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
International Equipment Trading Ltd. Relocates to Larger Office & Warehouse
International Equipment Trading Ltd.. (IET) recently moved its corporate headquarters to Mundelein, IL. The new office is approximately five miles from its previous location in Vernon Hills, IL. - January 30, 2016 - IET
Genelex Receives Innovative Technology Designation from Vizient, Inc. for YouScript® Software
Genelex receives Innovative Technology Designation from Vizient, Inc. for YouScript® software that reduces ER visits & hospitalizations with improved, gene-based medication management. Designation recognizes the development of new solutions that benefit the health care industry. - January 30, 2016 - Genelex Corp
ALPCO's New Stool-Based Gastroenterology Assays and Extraction Method Can Improve Lab Sample Processing Time by Up to 86%
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step, allowing labs to improve sample processing time by up to 86%. - January 26, 2016 - ALPCO
Eagle Biosciences Announces the Launch of Functional Leptin ELISA
An Esoteric Kit for Measurement of Functional, Receptor Binding Leptin Levels in Serum or Plasma - January 25, 2016 - Eagle Biosciences, Inc.
Children’s Healthcare of Atlanta Received $1M Research Grant from Enduring Hearts
Children’s Healthcare of Atlanta has received a generous grant of $1,000,000 from the Enduring Hearts Foundation to fund cardiac research to enhance the lives of children needing heart transplantation. Some of the research funded will be that of Michael Davis, Ph.D., Director of the... - January 22, 2016 - Enduring Hearts
Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio
New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016 - Braasch Biotech LLC
Bioo Scientific Completes ISO 9001:2008 Recertification Process
Bioo Scientific has been recertified for another three years under the international ISO 9001:2008 standard (ISO CI#: SARA-2009-CA-0114-A). - January 21, 2016 - Bioo Scientific